1. Home
  2. MIND vs KPTI Comparison

MIND vs KPTI Comparison

Compare MIND & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

N/A

Current Price

$4.46

Market Cap

43.0M

Sector

Industrials

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$0.88

Market Cap

36.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIND
KPTI
Founded
1987
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.0M
36.7M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
MIND
KPTI
Price
$4.46
$0.88
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $7.25
AVG Volume (30 Days)
88.1K
★ 1.2M
Earning Date
09-08-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.77
N/A
EPS
★ N/A
N/A
Revenue
$42,675,000.00
★ $146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$73.65
$27.98
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 0.57
52 Week Low
$3.63
$1.20
52 Week High
$14.50
$10.99

Technical Indicators

Market Signals
Indicator
MIND
KPTI
Relative Strength Index (RSI) 50.65 23.57
Support Level $4.25 N/A
Resistance Level $4.70 $2.16
Average True Range (ATR) 0.20 0.16
MACD 0.05 0.04
Stochastic Oscillator 74.19 0.00

Price Performance

Historical Comparison
MIND
KPTI

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: